感染病患者多重耐药菌感染风险的分层.pptVIP

IDSA has updated its guidelines for empiric therapy of community-acquired pneumonia.1 An important consideration is appropriate use of antipseudomonal agents in this setting. For patients admitted to the hospital ICU with community-acquired pneumonia for whom pseudomonal infection is not an issue, ertapenem is a preferred treatment option.1 Patients who have community-acquired pneumonia and risk factors for pseudomonal infection—including severe structural lung disease such as bronchiectasis, or recent antibiotic therapy or recent prior hospitalization, especially in the ICU—require differ